- Investindustrial signed a binding put option to sell Benvic's compounds business to ICIG, pending regulatory approval.
- Benvic generates approximately €500 million in sales with 630 full-time employees.
- The sale is expected to close by the end of the year.
- Benvic's medical activities in Italy will remain with Investindustrial.
Transaction Overview
Investindustrial has signed a binding put option to sell Benvic's compounds business to International Chemical Investors Group (ICIG). The sale is subject to the consultation of Benvic’s works council in France and EU anti-trust approval, with closing expected by the end of the year. Benvic’s medical activities in Italy will remain with Investindustrial funds.
Benvic's Business and Performance
Benvic Compounds develops, produces, and markets thermoplastic solutions based on PVC, engineering polymers, and bio-polymers compounds. The company has approximately €500 million in sales and employs 630 full-time employees. Benvic is a leading PVC compounder in Europe and holds a significant position in specialty compounding applications in the US.
Growth and Development
Under Investindustrial’s ownership, Benvic has transformed into a global leader in thermoplastic solutions through eight add-on acquisitions across Europe and the US. The company has diversified its end-markets and products, improved operations, and strengthened its management team.
ESG Initiatives
Benvic has established itself as a leader in ESG matters, implementing action plans to reduce CO2 emissions and achieve carbon neutrality. The company completed an ESG-linked refinancing and has focused on developing sustainable and renewable materials and solutions.
